Results 211 to 220 of about 30,431 (245)

[Janus kinase inhibitors].

Zeitschrift fur Rheumatologie, 2013
Janus protein tyrosine kinase (JAK) inhibitors are new therapeutic targets in the treatment of rheumatoid arthritis. Tofacitinib has shown good clinical efficacy in phase II and III studies with American College of Rheumatology (ACR) 20 response rates over 50% for monotherapy and in combination with methotrexate (MTX).
E, Ostermeier, P, Roll, H-P, Tony
openaire   +1 more source

Thromboembolism and Janus Kinase Inhibitors

Drug Safety, 2020
Fowzia Ibrahim, David L. Scott
openaire   +3 more sources

INHIBITORS OF JANUS KINASES

2009
SIU TONY, YOUNG JONATHAN, ALTMAN MICHAEL, NORTHRUP ALAN, KATCHER MATTHEW, KUMARASINGHE ELLALAHEWAGE SATHYAJITH, KOZINA EKATERINA, PETERSON SCOTT, CHILDERS MATTHEW   +8 more
  +13 more sources

Le filgotinib (Jyseleca®), un inhibiteur des Janus kinases

Actualites Pharmaceutiques, 2022
Sébastien Fauré
exaly  

Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway

Frontiers in Chemistry, 2022
Guilin Chen, Gui-Lin Chen, Guo Ming-Quan   +2 more
exaly  

Janus kinases inhibitors

Cahiers Santé Médecine Thérapeutique, 2022
El Mehdi Boudhar, M El Mandour, Abdelhafid Elguich, Hajar Sahimi, Hasna Hassikou   +4 more
openaire   +1 more source

Janus kinases in immune cell signaling

Immunological Reviews, 2009
Kamran Ghoreschi, John J O'Shea, Arian Laurence   +2 more
exaly  

Janus Kinase

2006
openaire   +2 more sources

Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors

Current Medicinal Chemistry, 2019
Francesca Wanda Rossi, Felice Rivellese, Amato De Paulis   +2 more
exaly  

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)

Bioorganic and Medicinal Chemistry Letters, 2009
Herbert Treutlein, Emmanuelle Fantino, Tracy Nero   +2 more
exaly